Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03296462
Other study ID # Pro00066652
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 3, 2016
Est. completion date July 10, 2019

Study information

Verified date May 2022
Source University of Alberta
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This RCT is a feasibility study to evaluate the Lois Hole Hospital for Women's Urogynecology Clinic's ability to recruit and randomize SUI patients to the proposed RCT, and to test the study procedures and follow-up schedule for participants. The study interventions used in the feasibility study will be training of (1) Hip Extension Rotation (HER) exercises alone, (2) HER exercises in combination with Pelvic Floor Muscle (PFM) exercises, or (3) PFM exercises alone (control/usual care) in the treatment of SUI.


Description:

Background: Hip External Rotation (HER) exercises are being adopted into physiotherapy practice for the treatment of stress urinary incontinence (SUI) despite little evidence compared to the proven effective standard of care treatment, pelvic floor muscle (PFM) exercises. A randomised clinical trial (RCT) is needed to determine whether HER exercise alone or in combination with PFM is more or less effective than PFM exercises alone. Objective: Before designing an RCT, a feasibility study is needed to evaluate the Lois Hole Hospital for Women's Urogynecology Clinic's ability to recruit and randomize SUI patients to the proposed RCT, and to test the study procedures and follow-up schedule for participants. Interventions: The interventions used in the feasibility study will be training of (1) HER exercises alone, (2) HER exercises in combination with PFM exercises, or (3) PFM exercises alone (control/usual care) in the treatment of SUI. Study design: RCT in which participants are randomly allocated 1:1:1 to each intervention. Outcome Measures: Feasibility outcomes will pertain to recruitment, adherence to training, appropriateness of outcome measures and completion rates. The design of the proposed RCT will be based on these feasibility outcomes. Outcome measures for the proposed RCT will include pelvic floor muscle strength, external hip rotator muscle strength, diary-reported urinary incontinence, incontinence related quality of life, and (to test patient mobility) six minute walk test and timed up and go test. Sample size: The proposed sample size is 30 participants. Duration of study: After recruitment, each woman will undergo 12 weeks of training, with the first outcome measure at the end of that period, and a further follow up at 24 weeks from recruitment.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date July 10, 2019
Est. primary completion date July 10, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Stress urinary incontinence - Attending Lois Hole Hospital for Women Urogynecology Clinic - Referred for physiotherapy for stress urinary incontinence - Able to toilet independently - Able to undertake hip rotation exercises - Able to speak and read English Exclusion Criteria: - Urge urinary incontinence - Using a pessary - Neurological or cognitive impairment - Using other treatment for incontinence - Unable to complete study forms - Unable to understand educational instruction

Study Design


Intervention

Other:
Hip external rotation exercise
Standardised HER exercise training by physiotherapist (plus video recording of exercises)
Pelvic floor muscle exercise
Standardised PFM exercise training by physiotherapist (plus video recording of exercises)

Locations

Country Name City State
Canada Lois Hole Hospital for Women, Royal Alexandra Hospital Edmonton Alberta

Sponsors (2)

Lead Sponsor Collaborator
University of Alberta Physiotherapy Alberta - College + Association

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility: achieve recruitment of 30 women over 12 months Is recruitment feasible? "Feasibility" is defined as achieving recruitment target of 30 recruits within 12 months 12 months
Primary Feasibility: achieve follow-up for 60% of recruits over 12 months Is follow-up complete for 60% of recruits? 12 months
Secondary Pelvic floor muscle strength Strength will be measured using Peritron perineometer 12 & 24 weeks
Secondary External hip rotator muscle strength Strength will be measured using Microfit ET3 12 & 24 weeks
Secondary Diary-reported urinary incontinence 3-day bladder diary to record amount and reason for leakage 12 & 24 weeks
Secondary Incontinence-related quality of life (distress) UDI-6 questionnaire (measure of distress caused by incontinence, 0 minimum to 100 maximum) 12 & 24 weeks
Secondary Incontinence-related quality of life (impact) IIQ-7 questionnaire (measure of impact of incontinence, 0 minimum to 100 maximum) 12 & 24 weeks
Secondary Patient mobility (walking) Six minute walk test - distance walked (metres) 12 & 24 weeks
Secondary Patient mobility "timed up and go" test - time in sconds 12 & 24 weeks
See also
  Status Clinical Trial Phase
Completed NCT02001714 - Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms N/A
Not yet recruiting NCT00523068 - Pharmacological vs Surgical Treatment for Mixed Incontinence Phase 4
Completed NCT00904969 - A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence N/A
Completed NCT00190827 - Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine) Phase 3
Completed NCT00190814 - Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge. Phase 3
Terminated NCT00247286 - Weighted Vaginal Cones Versus Biofeedback in the Treatment of Urodynamic Stress Incontinence: a Randomized Trial. Phase 4
Completed NCT01959347 - Combined Treatment for Mixed Incontinence Phase 3
Completed NCT00244296 - To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms Phase 4
Not yet recruiting NCT05570071 - A Study of the Use of Vaginal Radiofrequency Therapy in Treatment of SUI. N/A
Completed NCT02334878 - Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence Phase 3
Completed NCT01382602 - Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study Phase 3
Recruiting NCT02750878 - Surgical Consent Process for Trans-obturator Tape Slings. N/A
Completed NCT02296099 - Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence Phase 4
Completed NCT02599051 - Transobturator Verus Single Incision Slings N/A
Completed NCT00138749 - An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence. Phase 2
Terminated NCT03614611 - Canadian Experience With Contiform Intravaginal Device For The Treatment Of Stress Incontinence N/A
Completed NCT03722719 - The Knack on Female Stress Urinary Incontinence N/A
Active, not recruiting NCT02275728 - Pelvic Floor Muscle Training With and Without Biofeedback in Women With Stress Urinary Incontinence N/A
Terminated NCT01358214 - Quality of Life After Tension Free Transvaginal Sling / Tape Operation With a Titanized Surgical Tape (TiLOOP® Tape) N/A
Active, not recruiting NCT01323426 - Treatment of Stress Urinary Incontinence by Injection of Autologous Muscle Fibers Into the Urethral Sphincter. Phase 1/Phase 2